The obtained results contribute to the understanding of the NLRP3 inflammasome pathway in the context of breast pathologies and approve the ability of PTX-enriched GF-based scaffolds to counteract the growth of breast tumor cells by inducing NLRP3 inflammasome activation and pyroptosis cell death, acting as potential therapeutic scaffolds for breast cancer therapy. Here, NLRP3 is linked to breast carcinoma.